Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a) Aged at least 18 years b) Hospitalised c) Confirmed SARS-CoV-2 infection by nucleic acid based testing (RT-PCR, CB-NAAT, or TrueNAT) or antigen testing d) Moderate and severe COVID-19 pneumonia (SpO2 e) Decreasing supplemental oxygen requirements (Nasal prongs f) Hemodynamically stable g) Cooperative h) No medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial
Exclusion criteria
Exclusion criteria: a) MMSE b) Recent surgery, cardiovascular event (ACS, PE) c) Moderate-severe heart disease (NYHA grade III or IV) d) CLD with ascites e) Prior history of TB, COPD, asthma, ILD f) Pregnant and lactating women g) Difficulty in mobilisation (for 6MWT) h) Hemodynamically unstable i) Refusal of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of improvement in respiratory parameters as measured by S. George Respiratory questionnaire (SGRQ), 6 minute walk test (6MWT), mMRC dyspnea scale and single breath count.Timepoint: At discharge, 2 weeks, 1 month and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of improvement in quality of life: EQ5D5LTimepoint: At discharge, 2 weeks, 1 month and 3 months;Percentage of patients attaining SpO2 â?¥92% at different time points of follow upTimepoint: At discharge, 2 weeks, 1 month and 3 months | — |
Countries
India
Contacts
All India Institute of Medical Sciences, New Delhi